Valuation Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 8.120 USD | -1.46% |
|
-26.71% | -0.25% |
Company Valuation: Corbus Pharmaceuticals Holdings, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 77.1 | 13.84 | 26.72 | 143.7 | 150.8 | 157.1 | - | - |
| Change | - | -82.05% | 93.01% | 437.89% | 4.94% | 4.13% | - | - |
| Enterprise Value (EV) | 77.1 | 13.84 | 26.72 | 143.7 | 150.8 | 157.1 | 157.1 | 157.1 |
| Change | - | -82.05% | 93.01% | 437.89% | 4.94% | 4.13% | 0% | 0% |
| P/E | -1.66x | -0.33x | -0.59x | -3.21x | -1.38x | -1.48x | -1.41x | -1.4x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.04x | -0.37x | 0x | -0x | 0.21x | -0.29x | -1.53x |
| Capitalization / Revenue | 87.4x | - | - | - | - | 141x | 65.4x | 62.5x |
| EV / Revenue | 0x | - | - | - | - | 141x | 65.4x | 62.5x |
| EV / EBITDA | - | - | - | -0x | - | -1.38x | -1.34x | -0.88x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.33x | -1.17x | -0.9x |
| EV / FCF | -0x | -0x | - | -0x | -0x | -1.3x | -1.25x | -1.05x |
| FCF Yield | -62.6% | -271% | - | -29.1% | -42.8% | -77.1% | -79.9% | -95.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -11.1 | -10.15 | -10.31 | -3.68 | -5.9 | -5.48 | -5.749 | -5.801 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.8817 | - | - | - | - | 1.111 | 2.4 | 2.511 |
| EBITDA 1 | - | - | - | -48.13 | - | -114 | -117.3 | -179.2 |
| EBIT 1 | -55.99 | -39.84 | -45.08 | -48.72 | -85.31 | -118.4 | -134.7 | -174.3 |
| Net income 1 | -45.64 | -42.35 | -44.6 | -40.21 | -78.54 | -116.3 | -135.2 | -171.2 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 18.471 | 3.315 | 6.040 | 11.800 | 8.140 | 8.120 | 8.120 | 8.120 |
| Nbr of stocks (in thousands) | 4,174 | 4,176 | 4,424 | 12,179 | 18,529 | 19,341 | - | - |
| Announcement Date | 3/8/22 | 3/7/23 | 3/12/24 | 3/11/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48x | - | - | - | 157M | |
| 19.64x | 6.93x | 13.92x | 1.51% | 66.93B | |
| 31.94x | 9.24x | 44.54x | 0.04% | 61.97B | |
| -79.21x | 15.29x | -73.77x | -.--% | 28.26B | |
| 28.46x | 6.03x | 15.64x | -.--% | 24.59B | |
| -14.63x | 5.3x | -6.66x | -.--% | 24.3B | |
| 26.45x | 4.98x | 16.56x | -.--% | 19.41B | |
| 48.28x | 17.79x | 36.09x | 0.31% | 16.77B | |
| 1225.47x | 35.26x | 769.42x | -.--% | 14.18B | |
| -15x | 3382.33x | -17.29x | -.--% | 14B | |
| Average | 126.99x | 387.02x | 88.72x | 0.21% | 27.06B | |
| Weighted average by Cap. | 73.50x | 184.88x | 49.64x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRBP Stock
- Valuation Corbus Pharmaceuticals Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
